Clinical Trials
27 trialsPALANGI3
Centre Oscar Lambret
Nilotinib With Radiation for High Risk Chordoma
Massachusetts General Hospital
Proton Radiation for Chordomas and Chondrosarcomas
Abramson Cancer Center at Penn Medicine
PRIMHADRON
Hospices Civils de Lyon
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer
Bavarian Nordic
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Afatinib in Locally Advanced and Metastatic Chordoma
Leiden University Medical Center
QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma
NantCell, Inc.
Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
Jonsson Comprehensive Cancer Center
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Children's Oncology Group
BN Brachyury and Radiation in Chordoma
Bavarian Nordic
NCT-PMO-1601
University Hospital Heidelberg
Pemetrexed for the Treatment of Chordoma
Saint John's Cancer Institute
IMRiS
University College, London
CHORDOMES
Centre Hospitalier Universitaire de Saint Etienne
Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
National Institutes of Health Clinical Center (CC)
Stereotactic Body Radiotherapy for Spine Tumors
Mercy Research
Chordoma Family Study
National Institutes of Health Clinical Center (CC)
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
BioMed Valley Discoveries, Inc
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Medical College of Wisconsin
Trial of Dasatinib in Advanced Sarcomas
Sarcoma Alliance for Research through Collaboration
CH01
University of Florida
Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Massachusetts General Hospital
Efficacy and Safety of Imatinib in Chordoma
Novartis
Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Massachusetts General Hospital
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Novartis
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
Children's Oncology Group